A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza

NCT03336619 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1030

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: Nitazoxanide
DRUG: Placebo

Sponsor

Romark Laboratories L.C.